c-di-AMP is a new second messenger in Staphylococcus aureus with a role in controlling cell size and envelope stress.

Corrigan RM, Abbott JC, Burhenne H, Kaever V, Gründling A. · 2011

Read c-di-AMP is a new second messenger in Staphylococcus aureus with a role in controlling cell size and envelope stress. by Corrigan RM, Abbott JC, Burhenne H, Kaever V, Gründling A. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3164647.txt.

Introduction

Rebecca Corrigan and colleagues discovered a new signalling molecule in a major hospital pathogen in a 2011 paper in PLoS Pathogens. The bacterium's wall polymer is vital for growth, yet rare mutants survive without it. Sequencing those survivors revealed changes in one gene, pointing to a cyclic molecule the gene's enzyme destroys.

The team showed the molecule is genuinely made in this species by a dedicated builder enzyme, and that blocking its destruction sends its levels soaring. High levels thickened the wall's cross-linking, perhaps compensating for the missing polymer, and shrank cell size noticeably. The messenger thus helps control cell size and helps the bacterium endure wall stress, a fresh angle on a pathogen famous for drug resistance.

Catalog record

CREATORCorrigan RM, Abbott JC, Burhenne H, Kaever V, Gründling A.
YEAR2011
COLLECTIONPAPERS
FORMATTXT
FILE SIZE85 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3164647

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

c-di-AMP Is a New Second Messenger in Staphylococcus aureus with a Role in Controlling Cell Size and Envelope Stress By Rebecca M Corrigan, James C Abbott, Heike Burhenne, Volkhard Kaever, Angelika Gründling, Ambrose Cheung Published in: PLoS Pathogens DOI: 10.1371/journal.ppat.1002217 ABSTRACT Abstract The cell wall is a vital and multi-functional part of bacterial cells. For Staphylococcus aureus, an important human bacterial pathogen, surface proteins and cell wall polymers are essential for adhesion, colonization and during the infection process. One such cell wall polymer, lipoteichoic acid (LTA), is crucial for normal bacterial growth and cell division. Upon depletion of this polymer bacteria increase in size and a misplacement of division septa and eventual cell lysis is observed. In this work, we describe the isolation and characterization of LTA-deficient S. aureus suppressor strains that regained the ability to grow almost normally in the absence of this cell wall polymer. Using a whole genome sequencing approach, compensatory mutations were identified and revealed that mutations within one gene, gdpP (GGDEF domain protein containing phosphodiesterase), allow both laboratory and clinical isolates of S. aureus to grow without LTA. It was determined that GdpP has phosphodiesterase activity in vitro and uses the cyclic dinucleotide c-di-AMP as a substrate. Furthermore, we show for the first time that c-di-AMP is produced in S. aureus presumably by the S. aureus DacA protein, which has diadenylate cyclase activity. We also demonstrate that GdpP functions in vivo as a c-di-AMP-specific phosphodiesterase, as intracellular c-di-AMP levels increase drastically in gdpP deletion strains and in an LTA-deficient suppressor strain. An increased amount of cross-linked peptidoglycan was observed in the gdpP mutant strain, a cell wall alteration that could help bacteria compensate for the lack of LTA. Lastly, microscopic analysis of wild-type and gdpP mutant strains revealed a 13–22% reduction in the cell size of bacteria with increased c-di-AMP levels. Taken together, these data suggest a function for this novel secondary messenger in controlling cell size of S. aureus and in helping bacteria to cope with extreme membrane and cell wall stress. INTRODUCTION Staphylococcus aureus is a very prevalent human pathogen that permanently colonizes the nares and skin of approximately 20% of the population, while another 60% are colonized transiently [1]. Infections caused by this pathogen are becoming increasingly more difficult to treat due to its resistance to antibiotic therapy. Where once methicillin was the antibiotic of choice, now only around 60% of S. aureus isolates remain sensitive to this drug. There has also been a rise in the number of community acquired methicillin resistant S. aureus (CA-MRSA) cases in recent years often resulting in severe skin and soft tissue infections as well as invasive diseases such as sepsis, necrotizing pneumonia or osteomyelitis [2], [3]. The ability of S. aureus to cause such a wide range of diseases depends on many factors and is, in part, due to the diverse functions that are linked to its cell envelope. A myriad of proteins are embedded in this structure that allow bacteria to take up nutrients and adhere to diverse surfaces or niches within the human host. It also protects bacteria from environmental insults and at the same time allows the cells to sense and respond to changes in their surroundings, a function crucial for the survival of this pathogen in the host. In addition, the cell wall helps bacteria to maintain their shape and functions to counteract the high internal turgor pressure. Because the cell envelope has such essential functions, it also forms a weak point of the cell, as the inhibition of enzymes required for its synthesis is often lethal or leads to virulence defects. Therefore, this structure has been, and remains, an attractive target for therapeutic interventions. A typical cell wall of Gram-positive bacteria consists of proteins, peptidoglycan (PG) and the cell wall polymers wall teichoic acid (WTA), which is covalently linked to PG, and lipoteichoic acid (LTA), a polymer anchored to the outside of the bacterial membrane via a lipid moiety [4], [5], [6]. Synthesis of these cell wall components is highly coordinated and any mistakes can lead to cell lysis and death. From studies on the Gram-positive model organism Bacillus subtilis, it has emerged that PG and WTA synthesis enzymes form multi-protein complexes, which are further linked in this organism with cytoplasmic cell shape determining proteins, thereby coordinating and physically linking extracellular and intracellular synthesis processes [7], [8], [9], [10]. S. aureus LTA is an anionic cell wall polymer consisting of a linear chain of glycerolphosphate repeating units that is anchored via a glycolipid to the membrane [11]. The glycerolphosphate subunits are derived from the head group of the membrane lipid phosphatidylglycerol and polymerized on the outside of the cell by the membrane-linked lipoteichoic synthase enzyme LtaS to form the backbone chain [12], [13], [14], [15]. A large fraction of the glycerolphosphate subunits are substituted with D-alanine residues, a modification known to play a key role in the resistance of S. aureus and several other Gram-positive pathogens to cationic antimicrobial peptides [16], [17], [18], [19]. A function for this polymer in the formation of biofilms has been identified and multiple interactions between LTA and eukaryotic cells have been described [20], [21]. An interaction between LTA and macrophage scavenger receptors is thought to occur and help the host to clear bacterial infections [22], [23]. In agreement with this suggestion, scavenger receptor knockout mice are more susceptible to infection with S. aureus [24]. This polymer has also been shown to act as a ligand for Draper, a phagocytic receptor in Drosophila, which upon binding of LTA results in the phagocytosis of S. aureus by Drosophila hemocytes [25]. On the other hand, LTA is also thought to act as an anti-inflammatory molecule on skin cells by suppressing the TLR-3-mediated responses upon skin injury, a key pathway in the induction of inflammation [26]. Recently defined mutants lacking the entire LTA polymer have been constructed and phenotypic analysis indicated an important role for this polymer for normal bacterial growth and morphology [13], [27], [28], [29], [30]. LTA-deficient S. aureus strains have severely impaired growth and can initially only be propagated in medium containing high salt or sucrose concentrations, which are thought to act as osmoprotectants, or at low temperature [13], [27]. Even under conditions permissive for growth, these cells have severe morphological defects, such as an increased cell size and the tendency to clump. In addition, misplacement of cell division septa is observed, highlighting that the lack of LTA on the outside of the cell negatively affects fundamental processes in the cytoplasm of the cell. However, it is currently not known how these processes are coordinated. In this study we set out to investigate if S. aureus can find a way to survive without LTA and identified LTA-deficient suppressor strains that can grow and divide almost normally in the absence of this multi-functional cell wall polymer. Using a whole genome sequencing approach, it was determined that these strains have acquired mutations in a gene encoding a protein named GdpP (for GGDEF domain protein containing phosphodiesterase). We show that as a consequence of this mutation, the intracellular levels of the novel cyclic dinucleotide c-di-AMP increase drastically in the suppressor strain and gdpP mutant laboratory or CA-MRSA strains.

Read the complete text